Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43.1M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+640K
-
Total reported value, excl. options
-
$492M
-
Value change
-
+$9.67M
-
Put/Call ratio
-
0.01
-
Number of buys
-
39
-
Number of sells
-
-23
-
Price
-
$14.71
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q4 2022
87 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q4 2022.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 43.1M outstanding shares and own 77.66% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.29M shares), ORBIMED ADVISORS LLC (3.32M shares), CHI Advisors LLC (2.8M shares), Deep Track Capital, LP (2.73M shares), Redmile Group, LLC (2.68M shares), ARK Investment Management LLC (2.43M shares), MPM ASSET MANAGEMENT LLC (2.24M shares), T. Rowe Price Investment Management, Inc. (1.92M shares), BIOIMPACT CAPITAL LLC (1.64M shares), and FMR LLC (876K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.